Get started
Author

María Zaforteza Dezcallar

Observed names: Dezcallar, María Zaforteza, M Zaforteza Dezcallar, M. Zaforteza Dezcallar, M. Zaforteza-Dezcallar, María Zaforteza-Dezcallar, Zaforteza Dezcallar, María
ORCID: 0000-0001-8079-0302
Observed ORCID: 0000-0001-8079-0302
OpenAlex ID: A5061613273
Impact of an SMS intervention to support type 2 diabetes self-management: DiabeText clinical trial
2024 · Rocío Zamanillo-Campos, Maria Antonia Fiol-Deroque, et al. · British Journal of General Practice · 15
PDF
Atlas VPM: two decades informing on unwarranted variations in health care in Spain
2022 · Ester Angulo-Pueyo, Micaela Comendeiro-Maaløe, et al. · Research in Health Services & Regions · 11
PDF
DiabeText, a mobile health intervention to support medication taking and healthy lifestyle in adults with type 2 diabetes: Study protocol for a randomized controlled trial
2023 · Rocío Zamanillo-Campos, Maria Antonia Fiol-DeRoque, et al. · Contemporary Clinical Trials · 6
PDF
[Antibiotics policy in primary care. Practical experience in a health district. Primary Care Antibiotics Commission of the Mallorca Area].
1998 · C Rodríguez Moreno, F Campoamor Landín, et al. · PubMed · 6
Non-adherence to non-insulin glucose-lowering drugs: Prevalence, predictors and impact on glycemic control and insulin initiation. A longitudinal cohort study in a large primary care database in Spain
2023 · Rocío Zamanillo-Campos, María Zaforteza Dezcallar, et al. · European Journal of General Practice · 5
PDF
[Evolution of the outpatient antibiotic prescription between 2012 and 2018. Characteristics of the ABPresclín platform created for the analysis of antibiotic prescription in the health service of the Balearic Islands.]
2020 · Javier Arranz Izquierdo, Mª Asunción Boronat Moreiro, et al. · Revista Española de Salud Pública · 1
PDF
4CPS-277 Real-world survival and cost analysis of antifibrotic therapy in idiopathic pulmonary fibrosis: a multicentre retrospective study
2026 · T Garcia, G González Morcillo, et al. · European Journal of Hospital Pharmacy
Análisis en vida real de utilización y persistencia de terapia inmunomoduladora en artritis psoriásica
2026 · Gonzalo González Morcillo, Sergio Salvador Pareja, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
Persistencia del biológico en artritis psoriásica: cuando el sexo y la edad importan
2026 · Sergio Salvador Pareja, Elena Pérez García, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
Reevaluación del posicionamiento terapéutico en artritis psoriásica basada en ratio coste-efectividad incremental en vida real
2026 · Elena Pérez García, Sergio Salvador Pareja, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
EE236 Budget Impact Analysis of Biologic Drugs According to Persistance in the Treatment of Psoriasis and Psoriatic Arthritis in the Balearic Islands
2024 · G. González-Morcillo, J García-Calvo Navarro, et al. · Value in Health
Non-adherence to non-insulin glucose-lowering drugs: Prevalence, predictors and impact on glycemic control and insulin initiation. A longitudinal cohort study in a large primary care database in Spain
2023 · Zamanillo-Campos, Rocío, Dezcallar, María Zaforteza, et al. · Figshare
2SPD-006 Development of a prioritisation protocol for the use of immunoglobulins in view of the global supply problem
2022 · M Mejias Trueba, M Zaforteza Dezcallar, et al. · European Journal of Hospital Pharmacy
PDF
Ús de medicaments i envelliment
2017 · Juan Pou Bordoy, Sara Guerrero Bernat, et al. · Biblioteca Digital de les Illes Balears (Universitat de les Illes Balears)
CP-105 Effectiveness and safety of protease inhibitors telaprevir and boceprevir in the treatment of hepatitis C virus infections in clinical practice
2015 · O Delgado Sánchez, P Ventayol Bosch, et al. · European Journal of Hospital Pharmacy
Fàrmacs i gent gran
2012 · Àngela Aguiló Llobera, María Asunción Boronat Moreiro, et al. · Studia lulliana
PDF
Works count: 17
Citation count: 44
H-index: 5
I10-index: 2
Year
Topic
Type